SEC Filing Analysis: NEOGEN CORP (NEOG)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director acquired a small number of shares through the routine vesting of Restricted Stock Units (RSUs), a standard compensation event, not an open-market purchase.
• Market Impact: The transaction is negligible in size compared to the company's market capitalization and is not expected to have any market impact.

Company Information

Field	Value
Company	NEOGEN CORP
Ticker Symbol	NEOG
CIK	0000711377
Industry	In Vitro & In Vivo Diagnostic Substances

Insider Information

Field	Value
Name	BOEHM WILLIAM T
CIK	0001186582
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-27
Transaction Code	M (Exercise/Conversion)
Security Type	Common Stock
Shares Involved	3,553
Price Per Share	$6.07
Total Value	$21,566.71
Shares Owned After	47,913
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$21,566.71
% of Market Cap	0.0016%
Shares Transacted	3,553
% of Shares Outstanding	0.0016%
Post-Transaction Ownership	47,913 shares (0.022% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value of approximately $21.6k is insignificant against NEOGEN's $1.35 billion market capitalization.
• Ownership Concentration: The director's post-transaction ownership of 47,913 shares represents a very small fraction (0.022%) of the total shares outstanding, indicating low concentration.
• Dilution Impact: As this is the settlement of previously granted RSUs, the dilutive effect was already anticipated by the market. The issuance of 3,553 new shares has a negligible impact (0.0016%) on the total shares outstanding.
• Transaction Significance: The transaction is classified as low significance. Both its value relative to market cap and the number of shares relative to the total outstanding are well below the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a pre-scheduled compensation event (RSU vesting), not a discretionary open-market trade. It does not signal a change in the insider's sentiment towards the company's future prospects.

Volume & Sentiment

• Expected Volume Impact: None. The transaction is not an open-market trade and will not affect trading volume.
• Sentiment Indicator: Neutral. The market typically views RSU vesting as a routine part of executive compensation.

Investment Insights

Positive Market Indicators

• The filing shows the insider is retaining the shares acquired, which is a neutral-to-positive action compared to an immediate sale.

Risk Factors

• No risk factors are indicated by this specific filing.

Key Takeaways

1. Routine Compensation: The transaction is the vesting of RSUs, a common form of equity compensation for directors and executives.
2. Low Materiality: The value of the transaction is less than 0.002% of the company's market cap, making it financially immaterial.
3. No Market Signal: This event does not provide new information about the insider's view on the company's valuation or outlook.

Additional Context

Transaction Notes

• Special Circumstances: The filing's remarks clarify that Restricted Stock Units (RSUs) vested and were settled for an equal number of common stock shares. The 'M' code signifies the conversion of a derivative (the RSU) into a non-derivative security (common stock).
• Market Environment: This is a routine corporate action independent of the broader market environment.